The challenge of researchers has always been to find innovative drugs that retain analgesic efficacy without the debilitating side effects of conventional MOR agonists, especially respiratory depression, as the primary cause of opioid-related overdose mortality. Here, OPRM1 is linked to Respiratory insufficiency due to muscle weakness.